# Telix Pharmaceuticals Limited (TLPPF)

> Healthcare · AU · Reports in AUD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TLPPF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 1.22B | $ -10.86M | $ -77.63M | $ 784.94M | $ 622.65M |
| 2024 | $ 802.02M | $ 51.12M | $ 9.21M | $ 581.45M | $ 568.21M |
| 2023 | $ 533.25M | $ 5.53M | $ 13.89M | $ 17.45M | $ 148.91M |
| 2022 | $ 181.80M | $ -118.19M | $ -88.38M | $ 10.45M | $ 80.01M |
| 2021 | $ 9.06M | $ -96.08M | $ -72.40M | $ 2.54M | $ 2.16M |
| 2020 | $ 6.29M | $ -54.16M | $ 1.98M | $ 2.21M | $ 79.02M |
| 2019 | $ 4.30M | $ -34.36M | $ -29.35M | $ 2.13M | $ 70.08M |
| 2018 | $ 243.7K | $ -17.28M | $ -25.93M | $ 1.73M | $ 52.90M |
| 2017 | $ 62.1K | $ -12.10M | $ -7.69M | $ 345.4K | $ 49.29M |
| 2016 | $ 0 | $ 1.97M | $ 1.8K | N/A | N/A |
| 2015 | $ 0 | $ -173.9K | $ 0 | N/A | N/A |
| 2000 | $ 0 | $ -1.00M | N/A | $ 0 | $ 9.04M |
| 1999 | $ 0 | $ 0 | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.26 |
| Liabilities / Eq | 1.85 |
| Current Ratio | 1.43 |

## Other views

- [Metrics](https://sponda.capital/en/TLPPF.md)
- [Charts](https://sponda.capital/en/TLPPF/charts.md)
- [Compare](https://sponda.capital/en/TLPPF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-23.